[Clinical trial of a new chemotherapeutic combination designated Ro 6-2580 in bronchopneumopathy in adults].
D000328:Adult; D000367:Age Factors; D000890:Anti-Infective Agents / Q000008:administration & dosage*; D001991:Bronchitis / Q000188:drug therapy*; D004338:Drug Combinations; D004357:Drug Synergism; D005260:Female; D005493:Folic Acid Antagonists / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011014:Pneumonia / Q000188:drug therapy*; D011743:Pyrimidines / Q000008:administration & dosage*; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D013420:Sulfamethoxazole / Q000008:administration & dosage*; D014295:Trimethoprim / Q000008:administration & dosage / Q000627:therapeutic use
D000890:Anti-Infective Agents; D004338:Drug Combinations; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole
Ssais cliniques d'une association chimiothĕrapique nouvele dite Ro 6-2580 dans les broncho-pneumopathies de l'adulte.